Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,450,857
- Total 13F shares
- 43,391,345
- Share change
- +2,835,764
- Total reported value
- $1,426,965,052
- Put/Call ratio
- 0.85%
- Price per share
- $32.89
- Number of holders
- 161
- Value change
- +$102,534,235
- Number of buys
- 95
- Number of sells
- 67
Quarterly Holders Quick Answers
What is CUSIP 87650L103?
CUSIP 87650L103 identifies TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87650L103:
Top shareholders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
3/4/5
|
Company · 10%+ Owner |
8%
|
3,412,486
|
$92,751,369 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.7%
|
3,266,714
|
$88,789,285 | — | 30 Jun 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
5.7%
|
2,435,416
|
$66,194,607 | — | 30 Jun 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
5.3%
|
2,254,797
|
$61,285,382 | — | 30 Jun 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
5.2%
|
2,197,385
|
$59,724,924 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.7%
|
1,989,693
|
$54,079,856 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
4.4%
|
1,884,685
|
$51,225,738 | — | 30 Jun 2024 | |
| Vivo Capital IX, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,469,001
|
$49,380,020 | — | 05 May 2022 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.7%
|
1,587,527
|
$43,148,984 | — | 30 Jun 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
3.5%
|
1,479,868
|
$40,222,811 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.1%
|
1,296,416
|
$35,236,587 | — | 30 Jun 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.5%
|
1,063,422
|
$28,903,810 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
925,639
|
$25,158,868 | — | 30 Jun 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.9%
|
800,277
|
$21,751,529 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
773,235
|
$21,020,137 | — | 30 Jun 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
1.6%
|
670,459
|
$18,223,000 | — | 30 Jun 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.5%
|
627,578
|
$17,057,570 | — | 30 Jun 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
1.4%
|
594,325
|
$16,153,754 | — | 30 Jun 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
1.4%
|
590,000
|
$16,036,200 | — | 30 Jun 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
1.3%
|
565,550
|
$15,371,649 | — | 30 Jun 2024 | |
| TCG Crossover Management, LLC |
13F
|
Company |
1.3%
|
556,317
|
$15,120,696 | — | 30 Jun 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.2%
|
500,000
|
$13,590,000 | — | 30 Jun 2024 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
1.2%
|
500,000
|
$13,590,000 | — | 30 Jun 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.1%
|
463,240
|
$12,591,000 | — | 30 Jun 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.1%
|
454,991
|
$12,367,000 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1%
|
434,342
|
$11,805,416 | — | 30 Jun 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.99%
|
420,758
|
$11,436,202 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.96%
|
406,899
|
$11,056,962 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.92%
|
391,563
|
$10,642,683 | — | 30 Jun 2024 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.92%
|
389,600
|
$10,589,328 | — | 30 Jun 2024 | |
| J. Goldman & Co LP |
13F
|
Company |
0.91%
|
387,161
|
$10,523,036 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.91%
|
385,085
|
$10,466,609 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.86%
|
364,463
|
$9,906,104 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.82%
|
348,586
|
$9,474,567 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.72%
|
307,600
|
$8,360,568 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.69%
|
291,275
|
$7,918,000 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.64%
|
269,793
|
$7,332,974 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.62%
|
261,879
|
$7,117,871 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
253,016
|
$6,876,975 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.57%
|
243,112
|
$6,607,784 | — | 30 Jun 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.55%
|
235,000
|
$6,387,300 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.53%
|
226,879
|
$6,166,571 | — | 30 Jun 2024 | |
| BOONE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.51%
|
216,047
|
$5,872,157 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.49%
|
207,489
|
$5,639,551 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.48%
|
205,551
|
$5,586,876 | — | 30 Jun 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.47%
|
200,094
|
$5,438,555 | — | 30 Jun 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.43%
|
181,066
|
$4,921,373 | — | 30 Jun 2024 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
0.4%
|
170,000
|
$4,620,600 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.3%
|
127,328
|
$3,460,776 | — | 30 Jun 2024 | |
| Baird Financial Group, Inc. |
13F
|
Company |
0.29%
|
123,778
|
$3,364,286 | — | 30 Jun 2024 |
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) as of Q3 2024
As of 30 Sep 2024,
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,391,345 shares.
The largest 10 holders included
BlackRock, Inc., RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, TANG CAPITAL MANAGEMENT LLC, MORGAN STANLEY, COWEN AND COMPANY, LLC, JENNISON ASSOCIATES LLC, VANGUARD GROUP INC, Frazier Life Sciences Management, L.P., and PERCEPTIVE ADVISORS LLC.
This page lists
161
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
147
Q3 2024 holders
161
Holder diff
14
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.